Nabil Natafgi, PhD, MPH, CPH is a Postdoctoral Fellow in Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy.
Nabil Natafgi joined the department in June 2017 after completing his PhD in Health Services and Policy at the University of Iowa. Prior to entering the graduate program at Iowa, Nabil received a Master of Public Health (MPH) in Health Management and Policy and BS in Medical Laboratory Sciences from the American University of Beirut, Lebanon. His research interests focus on quality of care and patient safety, performance measurement and reporting, telehealth effectiveness and evaluation, and patient-centered outcomes research (PCOR).
In addition to his postdoctoral fellowship at the University of Maryland, Baltimore, Nabil also serves as an Adjunct Assistant Professor at the University of Iowa Colle of Public Health, where he teaches Introduction to Public Health.
Prior to coming to UMB, Nabil worked with Professor Marcia Ward at the Rural Telehealth Research Center (RTRC) on a number of projects examining the effectiveness and value of telehealth interventions in rural areas. He has published more than 18 peer-reviewed articles in prominent health services research journals. He has received several awards including The Bonnie J. and Douglas S. Wakefield Award for HMP Doctoral Student Performance (2016 and 2017), the College of Public Health (CPH) Board of Advisors award (2016), and the Milford E. Barnes Award for student excellence (2017). Nabil has also been recently inducted into the Delta Omega Honorary Society in Public Health for his outstanding accomplishments and major contributions to the field in public health.
At the University of Maryland School of Pharmacy, Nabil is currently engaged in qualitative analysis and patient-centered outcomes research (PCOR) working closely with academic, patient, and other stakeholder partners under the supervision of Professor C. Daniel Mullins. In addition, Nabil works on a number of other research projects that are part of the AHRQ-funded PATIENTS program as well as other projects funded by NIH, PCORI, and other federal and state agencies, foundations, and private corporations.